Tabula Rasa HealthCare, Inc.

TRHC · NASDAQ
Analyze with AI
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenue$299,516$331,260$297,219$284,707
% Growth-9.6%11.5%4.4%
Cost of Goods Sold$232,603$233,356$204,812$181,355
Gross Profit$66,913$97,904$92,407$103,352
% Margin22.3%29.6%31.1%36.3%
R&D Expenses$14,483$19,791$18,180$21,739
G&A Expenses$74,974$73,759$65,378$50,897
SG&A Expenses$85,465$99,728$86,925$76,170
Sales & Mktg Exp.$10,491$25,969$21,547$25,273
Other Operating Expenses$23,347$47,706$45,040$34,276
Operating Expenses$123,295$167,225$150,145$132,185
Operating Income-$56,382-$69,321-$57,738-$28,833
% Margin-18.8%-20.9%-19.4%-10.1%
Other Income/Exp. Net-$20,563-$9,107-$20,743-$15,986
Pre-Tax Income-$76,945-$78,428-$86,134-$48,635
Tax Expense$389$627-$5,168-$16,199
Net Income-$77,334-$79,055-$80,966-$32,436
% Margin-25.8%-23.9%-27.2%-11.4%
EPS-3.18-3.39-3.71-1.57
% Growth6.2%8.6%-136.3%
EPS Diluted-3.18-3.39-3.71-1.57
Weighted Avg Shares Out24,29323,29121,81520,622
Weighted Avg Shares Out Dil24,29323,29121,81520,622
Supplemental Information
Interest Income$0$0$0$0
Interest Expense$9,034$9,107$20,743$15,986
Depreciation & Amortization$31,742$47,706$45,040$34,276
EBITDA-$27,135-$21,615-$20,351$1,627
% Margin-9.1%-6.5%-6.8%0.6%